Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium oxide vs riboflavin for prevention of migraine attacks in children
IRCT20251020067696N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium oxide and riboflavin in migraine (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Nov 2025; status: completed.
02
Drugs
magnesium oxideriboflavin
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20251020067696N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251020067696N1.